Delivering Results: Science 37’s Direct-to-Patient Site for CNS Trials

Decentralized clinical trials have been widely discussed in recent years; however, Science 37 has extensive experience implementing these models in practice—building real-world evidence, refining methodologies, and advancing research in central nervous system (CNS) disorders.

Through its Direct-to-Patient Site, Science 37 has helped clinical trial sponsors accelerate enrollment among geographically dispersed and hard-to-reach populations, demonstrating the feasibility and effectiveness of remote participation in complex CNS studies.

This poster summarizes key achievements and results from seven completed CNS trials, including:

• Bipolar Depression with Suicidal Ideation
• Fragile X Syndrome
• Late-Onset Tay-Sachs/Sandhoff Disease
• Narcolepsy
• Parkinson’s Disease
• Peripartum Depression
• Treatment-Resistant Major Depressive Disorder

For a detailed overview of these studies and their outcomes, download the full poster below.

Authors:

Christopher Reist, MD
Medical Director, Psychiatry and Behavioral Sciences
Science 37

David Kudrow, MD
Medical Director, Neurology
Science 37